Headline News about Johnson & Johnson
![](https://cdn.benzinga.com/files/images/story/2023/12/05/jnj_1.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
![](https://cdn.pixabay.com/photo/2016/11/27/21/42/stock-1863880_960_720.jpg)
![](https://investorplace.com/wp-content/uploads/2023/07/growth-stock-hands-coins-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/04/jnjioffice3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
This Is What Whales Are Betting On Johnson & Johnson
November 27, 2023
Via Benzinga
![](https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp)
![](https://cdn.benzinga.com/files/images/story/2023/12/03/oxy_supreme_court.jpg?width=1200&height=800&fit=crop)
Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity
December 03, 2023
Via Benzinga
Topics
Bankruptcy
![](https://g.foolcdn.com/editorial/images/756773/gettyimages-1186957660.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/02/shutterstock_2256695601.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/01/jnjioffice3.jpg?width=1200&height=800&fit=crop)
Johnson & Johnson Gets Analyst Upgrade Noting Bullish Pharma & MedTech Projections
December 01, 2023
Via Benzinga
![](https://images.pexels.com/photos/5849595/pexels-photo-5849595.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](https://investorplace.com/wp-content/uploads/2022/07/healthcare-1600.jpg)
![](https://g.foolcdn.com/editorial/images/756464/buffett19-tmf.jpg)
![](https://d1ty0e8cxefhfl.cloudfront.net/member/danielle-berkowitz/user_content/ckimages/orig_corona.png)
![](https://investorplace.com/wp-content/uploads/2023/11/blue-chip-stocks-tech-ai-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/blue-chip-newspaper.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/etf-1600-3.png)
![](https://cdn.benzinga.com/files/images/story/2023/11/29/fda-social-graphic.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/01/dividend-stocks-1600.jpg)
![](https://g.foolcdn.com/editorial/images/756177/individual-investor-looking-at-stock-charts-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/Cradle-Biotech-Logo.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/09/robotics-hands-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2019/11/warren-buffett1600.jpg)
![](https://g.foolcdn.com/editorial/images/756026/gettyimages-woman-points-at-computer-with-a-pen-to-show-something-to-a-colleague.jpg)
![](https://g.foolcdn.com/editorial/images/756085/a-person-pointing-to-dollar-signs-next-to-a-chart-showing-steady-growth.jpg)
![](https://g.foolcdn.com/editorial/images/755827/stressed-investor-sitting-in-dark-at-computer.jpg)
![](https://g.foolcdn.com/editorial/images/755747/gettyimages-1398819387-1200x772-f9fd0c6.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.